Athenex Announces Progress Update from Partner Almirall on Tirbanibulin Ointment

NEXT STORY
CRO Market value to cross $61 billion by 2025: Global Market Insights, Inc.
PREV STORY
Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors

Senior pharmaceutical executives with extensive experience in immuno-oncology, drug development, commercializing oncology medications and ...

author_avatar
NASDAQ Market News

American Gene Technologies Announces First Trial Participant Enrolled in Phase 1 Study of AGT103-T Against HIV

author_avatar
NASDAQ Market News

Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer

STAMFORD, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News